Top Markets
#1 OpenVPP OpenVPP +13,448.23%
#2 BugsCoin BugsCoin +49.61%
#3 GENIUS AI GENIUS AI +48.16%
#4 TAC TAC +34.76%
#5 Solidus Ai Tech Solidus Ai Tech +30.89%
#6 Zerebro Zerebro +28.49%
#7 Avici Avici +24.70%
#8 Swarms Swarms +19.08%
#9 Resolv RLP Resolv RLP +17.22%
#10 AI Rig Complex AI Rig Complex +12.79%
Coin of the day
OpenVPP OpenVPP
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Hikal Limited Hikal Limited

Hikal Limited

HIKAL
Kedudukan dalam Saham #10836
Hikal Limited, together with its subsidiaries, manufactures and sells various... Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal healthcare, biotech, crop protection, and specialty chemicals companies. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredient (APIs). The Crop Protection segment manufactures pesticides and herbicides. The company collaborates with other companies and offer solutions in contract research, custom synthesis, and custom manufacturing of intermediates and APIs. It also provides specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company was incorporated in 1988 and is headquartered in Navi Mumbai, India.
Harga Saham
$2.09
Modal Pasaran
$257.37M
Perubahan (1 hari)
0.76%
Perubahan (1 tahun)
-55.56%
Negara
IN
Perdagangan Hikal Limited (HIKAL)

Kategori

Healthcare
Hasil untuk Hikal Limited (HIKAL)
Hasil pada Dec 2025 TTM: $192.72M
Menurut laporan kewangan terkini daripada Hikal Limited, hasil semasa syarikat (TTM) ialah $192.72M. Pada tahun 2024, syarikat memperoleh hasil sebanyak $212.11M penurunan berbanding hasil pada tahun 2023 iaitu $243.94M. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Hikal Limited dari 2005 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
2026 (TTM) $192.72M -11.38%
2025 $217.45M 2.52%
2024 $212.11M -13.05%
2023 $243.94M -3.86%
2022 $253.73M 8.81%
2021 $233.19M 16.71%
2020 $199.81M -12.62%
2019 $228.67M 14.65%
2018 $199.44M 25.18%
2017 $159.32M 16.20%
2016 $137.11M -0.41%
2015 $137.68M -0.28%
2014 $138.07M 13.80%
2013 $121.33M -12.95%
2012 $139.37M 23.66%
2011 $112.71M -6.08%
2010 $120.00M 6.34%
2009 $112.84M -5.74%
2008 $119.71M 19.08%
2007 $100.53M -1.80%
2006 $102.37M 34.19%
2005 $76.29M 0.00%
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPSEY.US
 $4.43B 2,200.95%
FR
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MKGAF.US
 $24.76B 12,745.78%
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
TAK.US
 $28.60B 14,738.56%
JP
Zoetis Inc. Zoetis Inc.
Zoetis Inc.
ZTS.US
 $9.47B 4,812.39%
US
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.31B 3,175.81%
IN